Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of atorvastatin calcium and proanthocyanidins
Atorvastatin calcium (ATV) and proanthocyanidins (PAC) have a strong antioxidant activity, that can benefit to reduce the atherosclerotic plaque progression. Unfortunately, the bioavailability of ATV is greatly reduced due to its limited drug solubility while the PAC drug is unstable upon exposure t...
محفوظ في:
| المؤلفون الرئيسيون: | Maslizan, Mardhiah, Haris, Muhammad Salahuddin, Ajat, Mokrish, Md Jamil, Siti Nurul Ain, Azhar, Shah Christirani, Zahid, N. Idayu, Mat Azmi, Intan Diana |
|---|---|
| التنسيق: | مقال |
| منشور في: |
Elsevier BV
2024
|
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
بواسطة: Maslizan, Mardhiah
منشور في: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
بواسطة: Maslizan, Mardhiah
منشور في: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle /
بواسطة: Mardhiah Maslizan, -
Enzyme nanocarriers /
منشور في: (2015) -
Nanocarrier Technologies Frontiers of Nanotherapy /
منشور في: (2006)
